AudioScholar Gastroenterology Weekly

AudioScholar
  • 0.0 (0)
  • Medicine
  • Updated Weekly

Gastroenterology — a weekly podcast briefing of the most significant peer-reviewed gastroenterology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

  1. Aug 12

    This Week in Gastroenterology — Aug 11, 2026

    Welcome to This Week in Gastroenterology. This week we're covering 10 notable papers spanning interventional endoscopy and biliary access, liver disease frameworks from hepatocellular carcinoma to steatotic liver disease, and a set of studies reshapi… This week's papers: 1. BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma — Hepatology 2026 2. EUS-guided biopsy using 19-gauge Franseen needle versus percutaneous ultrasound-guided biopsy using 18-gauge full-core cutting needle for parenchymal liver dis… — Gastrointestinal Endoscopy 2026 3. Advanced cannulation techniques vs early EUS-BD in case of difficult biliary cannulation in patients with DMBO: an international propensity score-matched analy… — American Journal of Gastroenterology 2026 4. A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study — The Lancet Gastroenterology & Hepatology 2026 5. Clinical impact of disposable elevator-cap duodenoscopes on post-ERCP cholangitis: a prospective cohort study — Gastrointestinal Endoscopy 2026 6. Inflammatory Bowel Disease — Annals of Internal Medicine 2026 7. Meta-Analysis: Prevalence of Non-Helicobacter pylori, Non-NSAID Peptic Ulcer Disease — Alimentary Pharmacology and Therapeutics 2026 8. Screen-Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long-Term Outcomes and Mortality — Alimentary Pharmacology and Therapeutics 2026 9. The dynamic spectrum of steatotic liver disease: the global perspective — Nature Reviews Gastroenterology & Hepatology 2026 10. Appendectomy before or after ulcerative colitis diagnosis is not associated with improved long-term outcomes: a multicenter real-world study — Inflammatory Bowel Diseases 2026 Listen at https://audioscholar.cc/episode/tvcme9kqc5

  2. Aug 7

    This Week in Gastroenterology — Aug 6, 2026

    Welcome to This Week in Gastroenterology. This week we're covering 10 notable papers spanning positioning of advanced therapies in inflammatory bowel disease, risk stratification and finite therapy in chronic liver disease, and the quality and safety… This week's papers: 1. Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study — Clinical Gastroenterology and Hepatology 2026 2. Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial) — Hepatology 2026 3. Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the Eng… — Gut 2026 4. Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort — Gastroenterology 2026 5. Clinical Efficacy of Endoscopic Ultrasound-Guided Gastroenterostomy, Enteral Stenting, and Surgical Gastrojejunostomy for Malignant Gastric Outlet Obstruction:… — Gastrointestinal Endoscopy 2026 6. Reproducibility of Biomarkers in MASLD: A Benchmark for Clinically Meaningful Change in Serially Measured Non-Invasive Tests — Journal of Hepatology 2026 7. Effect of a single dose antibiotic prophylaxis in scheduled bile duct interventions in Primary Sclerosing Cholangitis — Gastrointestinal Endoscopy 2026 8. Thirty-day Mortality Among Jehovah's Witness Patients with Gastrointestinal Bleeding Who Decline Blood Transfusion: A Retrospective Cohort Study — American Journal of Gastroenterology 2026 9. Reutilization of biologics for postoperative Crohn's disease recurrence prevention is effective — Inflammatory Bowel Diseases 2026 10. Artificial Intelligence Automated Assessment of Colonoscopy Quality Metrics — American Journal of Gastroenterology 2026 Listen at https://audioscholar.cc/episode/j65m69rf2h

  3. Jul 31

    This Week in Gastroenterology — Jul 31, 2026

    Welcome to This Week in Gastroenterology. This week we're covering 9 notable papers spanning advances in metabolic liver disease and portal hypertension, endoscopic innovations in esophageal disorders, and evolving paradigms in diagnostic criteria, s… This week's papers: 1. Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 Subset — Alimentary pharmacology & therapeutics 2026 2. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome V versus Rome IV Crit… — Clinical gastroenterology and hepatology 2026 3. Rate and clinical predictors of skeletal muscle loss in patients with cirrhosis — Gut 2026 4. Improving follow-up of abnormal stool test results used for colorectal cancer screening — Gastrointestinal endoscopy 2026 5. Decompression of portal hypertension by transjugular intrahepatic portosystemic shunt reverses markers of gut barrier dysfunction and cirrhosis-associated immu… — Gut 2026 6. Peroral Endoscopic Myotomy versus Flexible Endoscopic Septotomy for Zenker's Diverticulum: A Cost-Effectiveness Analysis — Gastrointestinal endoscopy 2026 7. Peroral Endoscopic Myotomy for Pediatric Achalasia: 36-Month Outcomes from a Single-Center Cohort Study — Gastrointestinal endoscopy 2026 8. Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality — Gut 2026 9. Review Article: Accelerating Coeliac Disease Clinical Trials-Beyond Celiac Meeting With Industry, Academics, Patients and the FDA — Alimentary pharmacology & therapeutics 2026 Listen at https://audioscholar.cc/episode/jxehaf7x3v

  4. Jul 24

    This Week in Gastroenterology — Jul 23, 2026

    Welcome to This Week in Gastroenterology. This week we're covering 9 notable papers spanning inflammatory bowel disease diagnostics and advanced therapeutics, functional gastrointestinal disorders and motility, and hepatology. Let's dive in. In the… This week's papers: 1. Oral vancomycin is not associated with meaningful changes in liver-related endpoints among adults with primary sclerosing cholangitis: A randomized, placebo-co… — The American journal of gastroenterology 2026 2. New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC. — Clinical gastroenterology and hepatology 2026 3. Clinical Trial: Effectiveness and Safety of a Novel Anal Insert Device for Treatment of Faecal Incontinence. — Alimentary pharmacology & therapeutics 2026 4. Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a mul… — Inflammatory bowel diseases 2026 5. Prior decompensation Identifies Patients at High Mortality Risk Despite Standard Therapy After Variceal Hemorrhage: An IPD Meta-analysis. — Clinical gastroenterology and hepatology 2026 6. Singing Therapy versus Diaphragmatic Breathing for Supragastric Belching: A Multicenter Randomized Controlled Trial. — Clinical gastroenterology and hepatology 2026 7. Eosinophilic gastrointestinal diseases. — Nature reviews. Disease primers 2026 8. Clinical Trial: Multi-Strain Probiotic Improves Bile Acid Profile, Microbiome, and Metabolomic Parameters in Patients With History of Bile Acid Malabsorption-A… — Alimentary pharmacology & therapeutics 2026 9. Pushing the boundaries of liver resection for liver cancer. — Journal of hepatology 2026 Listen at https://audioscholar.cc/episode/eb7tp7qgqf

  5. Jul 17

    This Week in Gastroenterology — Jul 16, 2026

    Welcome to This Week in Gastroenterology. This week we're covering eight notable papers spanning advanced therapeutics and clinical trial frameworks in inflammatory bowel disease, novel diagnostic and prognostic models in hepatology, and updated clin… This week's papers: 1. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. — The Lancet Gastroenterology & Hepatology 2026 2. Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. — The Lancet Gastroenterology & Hepatology 2026 3. Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label… — The Lancet Gastroenterology & Hepatology 2026 4. A machine learning approach to non-invasive prediction of hepatic decompensation in compensated advanced chronic liver disease: the CIRI model. — Journal of Hepatology 2026 5. Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus. — Nature Reviews Gastroenterology & Hepatology 2026 6. Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality. — Gut 2026 7. International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials. — Gut 2026 Listen at https://audioscholar.cc/episode/h5y9yu6eq4

  6. Jul 8

    This Week in Gastroenterology — Jul 7, 2026

    Welcome to This Week in Gastroenterology. This week we're covering 9 notable papers spanning advanced hepatology and portal hypertension, safety and long-term outcomes in inflammatory bowel disease, innovations in interventional endoscopy, and emergi… This week's papers: 1. The Comparative Effectiveness of Carvedilol Versus Other Nonselective β-Blockers in Cirrhosis. — Annals of Internal Medicine 2026 2. Randomized trial comparing 5-year follow-up of first-line infliximab to conventional therapy in paediatric Crohn's disease. — Clinical Gastroenterology and Hepatology 2026 3. SINGLE-BLINDED RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECT OF UNDERWATER VERSUS CARBON DIOXIDE INSUFFLATION DURING PERORAL ENDOSCOPIC MYOTOMY ON POST-PROC… — Gastrointestinal Endoscopy 2026 4. Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort. — Journal of Hepatology 2026 5. LOCAL RECURRENCE AFTER COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION: A LARGE INTERNATIONAL WESTERN MULTICENTER STUDY. — Gastrointestinal Endoscopy 2026 6. Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study. — Journal of Hepatology 2026 7. Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD. — Inflammatory Bowel Diseases 2026 8. Association of metabolic dysfunction-associated steatotic liver disease onset age with risk of incident type 2 diabetes. — Clinical Gastroenterology and Hepatology 2026 9. Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial. — Journal of Hepatology 2026 Listen at https://audioscholar.cc/episode/f8r4swnfks

  7. Jul 1

    This Week in Gastroenterology — Jun 30, 2026

    Welcome to This Week in Gastroenterology. This week we're covering eight notable papers spanning management strategies for inflammatory and functional luminal disorders, advancements and diagnostic limitations in endoscopy, and infectious drivers of… This week's papers: 1. Efficacy of gut-brain neuromodulators and brain-gut behaviour therapies for irritable bowel syndrome: systematic review and network meta-analysis — Gut 2026 2. Location of GI lesions with bleeding potential in patients with iron deficiency anemia: a multicenter prospective study — Gastrointestinal Endoscopy 2026 4. Inter and intra-observer agreement for the LST Classification in Large (>2cm) Colorectal Laterally Spreading Tumours — The American Journal of Gastroenterology 2026 5. A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial — Journal of Hepatology 2026 6. Clinical Outcomes of Primary versus Conversion Endoscopic Ultrasound-Guided Gallbladder Drainage after Percutaneous Drainage: A Multicenter Study — Gastrointestinal Endoscopy 2026 7. The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children — The American Journal of Gastroenterology 2026 8. Association of preoperative neoplasia and rectal cuff inflammation on initial pouchoscopy with subsequent neoplasia development in IBD patients with an IPAA: a… — Inflammatory Bowel Diseases 2026 Listen at https://audioscholar.cc/episode/myjjum8q75

  8. Jun 23

    This Week in Gastroenterology — Jun 22, 2026

    Welcome to This Week in Gastroenterology. This week we are covering eight notable papers spanning advanced risk-stratification models in colorectal and mucosal disease, emerging strategies in hepatology and liver transplantation, and cost-effective l… This week's papers: 1. Biological aging and generational shifts in early-onset cancer risk. — Nature Medicine 2026 2. Optimal Retention Duration of Prophylactic Pancreatic Duct Stents Placed During Endoscopic Retrograde Cholangiopancreatography: A Multicenter Randomized Contro… — Clinical Gastroenterology and Hepatology 2026 3. AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation. — Hepatology 2026 4. Cost-effectiveness of Microbiota Restoration Therapies for Recurrent Clostridioides difficile Infection. — The American Journal of Gastroenterology 2026 5. Balancing benefit and burden: rethinking post-polypectomy colonoscopy surveillance strategies. — The Lancet Gastroenterology & Hepatology 2026 6. Use of genetic analysis in adult cholestatic liver disease: lessons from progressive paediatric syndromes and cohort studies. — Gut 2026 7. Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumption. — Gut 2026 8. Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia. — Gut 2026 Listen at https://audioscholar.cc/episode/t59ptvmsju

See All (13)

About

Gastroenterology — a weekly podcast briefing of the most significant peer-reviewed gastroenterology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Information